Health Canada Approves Sanofi Genzyme’s Cerdelga to Treat Gaucher Disease Type 1
News
Health Canada has approved Cerdelga (eliglustat capsules), manufactured by Sanofi Genzyme, for treating Gaucher disease type 1 (GD1) — three years after the U.S. Food and Drug Administration gave its blessing to the ... Read more